Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity

NCT: NCT01082419 · COMPLETED

NCT IDNCT01082419
StatusCOMPLETED
Start Date2010-04
Completion2013-04

Brief Summary

Liver stiffness measurement (LSM) by non invasive methods is increasingly used to estimate liver fibrosis in patients with chronic liver diseases. However, there is growing evidence that fibrosis is not the only determinant of liver stiffness. Indeed inflammation, cholestasis, congestion could also interfere with stiffness measurements. Acoustic radiation force impulse imaging (ARFI) is a new technology to perform real time LSM. Using a standard ultrasonographic probe, it offers elastography with a flexible metering box at variable depth, allowing the examination of specific area.

Frequently Asked Questions

What is Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity?

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity is a clinical trial registered under NCT01082419. Current status: COMPLETED.

What is the status of NCT01082419?

The current status of NCT01082419 (Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity) is: COMPLETED.

When did Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity start?

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity started on 2010-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.